BridgeMD
New treatment option for Hospital Associated Disability
Official title Targeting Muscle Strength Loss Due to Hospitalization in Older Adults by Blood-flow Restriction Combined With an Electromyography-driven Serious Game.
ClinicalTrials.gov ID: NCT07294131
What this study is testing
- What it's testing
- This study investigates a new training method designed to help older adults preserve their muscle strength during hospitalization. When older adults are admitted to the hospital and spend long periods in bed, their muscles can weaken very quickly.
- Phase 2: a mid-size study of how well it works
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 and older. Healthy volunteers may be eligible.
You may be able to join if
- PATIENTS
- Hospitalized, and expected to remain hospitalized for approximately 14 days
- 65+ yrs
- Unable to bear weight or transfer independently and at high risk of muscle strength loss due to prolonged immobility
You likely can't join if
- Contraindications for physical exercise as assessed by the treating physician using the risk assessment tool proposed by Kacin et al. (2015) (can be...
- Contraindications for blood flow restriction as assessed by the treating physician (can be overruled by the physician)
- Cognitive impairment (MMSE score \< 19)
- Any condition that renders the patient unable to understand instructions or safely interact with the GHOSTLY+ system THERAPISTS Inclusion Criteria...
- They are licensed physiotherapists employed at one of the three participating clinical sites
- They are involved in the daily rehabilitation of hospitalized older adults. Exclusion Criteria: Therapists will be excluded from participation if
See the full eligibility criteria
- PATIENTS
- Hospitalized, and expected to remain hospitalized for approximately 14 days
- 65+ yrs
- Unable to bear weight or transfer independently and at high risk of muscle strength loss due to prolonged immobility
- Contraindications for physical exercise as assessed by the treating physician using the risk assessment tool proposed by Kacin et al. (2015) (can be overruled by the physician)
- Contraindications for blood flow restriction as assessed by the treating physician (can be overruled by the physician)
- Cognitive impairment (MMSE score \< 19)
- Any condition that renders the patient unable to understand instructions or safely interact with the GHOSTLY+ system THERAPISTS Inclusion Criteria: Therapists will be included if
- They are licensed physiotherapists employed at one of the three participating clinical sites
- They are involved in the daily rehabilitation of hospitalized older adults. Exclusion Criteria: Therapists will be excluded from participation if
- They are unable or unwilling to complete the GHOSTLY+ training
- They are not directly involved in the care of eligible patients during the study period
- They express any conflict of interest or ethical concern that may compromise the integrity of the study
The study team makes the final eligibility decision.
Where it's taking place
- Antwerp, Belgium
- Brussels, Belgium
- Leuven, Belgium
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Antwerp, Belgium; Brussels, Belgium; Leuven, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.